Global Bipolar Disorder Partnering Deals and Agreements Analysis Report 2010-2016 - Research and Markets

DUBLIN--()--Research and Markets has announced the addition of the "Global Bipolar Disorder Partnering 2010-2016" report to their offering.

The Global Bipolar Disorder Therapy Partnering Terms and Agreements since 2010 report provides understanding and access to partnering deals and agreements entered into by the world's leading healthcare companies.

The report provides an analysis of partnering deals. The majority of deals are discovery or development stage whereby the licensee obtains a right or an option right to license the licensor's technology. These deals tend to be multicomponent, starting with collaborative R&D, and commercialization of outcomes.

Understanding the flexibility of a prospective partner's negotiated deal terms provides critical insight into the negotiation process in terms of what you can expect to achieve during the negotiation of terms. Whilst many smaller companies will be seeking details of the payments clauses, the devil is in the details in terms of how payments are triggered - contract documents provide this insight where press releases do not.

This report provides the reader with the following key benefits:

  • In-depth understanding of deal trends since 2010
  • Access to headline, upfront, milestone and royalty data
  • Comprehensive access to multiple deals entered into by the world's biopharma companies since 2010
  • Insight into key deal terms included in contracts, where disclosed
  • Understand the key deal terms companies have agreed to in deals
  • Undertake due diligence to assess suitability of your proposed deal terms for partner companies

Key Topics Covered:

1 Bipolar Disorder Therapy partnering trends in numbers

  • By year
  • Most active
  • By industry sector
  • By deal type
  • By technology type
  • By stage of development

2 Most active dealmakers

3 Bipolar Disorder Partnering deals directory

  • By company A-Z
  • By deal value
  • By industry sector
  • By deal type
  • By stage of development
  • By technology area

4 Bipolar Disorder Partnering deals with a contract document

5 M&A in numbers

  • M&A in numbers - by year

6 Bipolar Disorder M&A deals directory

  • M&A deals directory - by company A-Z
  • M&A deals directory - by deal value

7 Financing in numbers

  • By year
  • By financing type

8 Bipolar Disorder Financing deals directory

For more information about this report visit http://www.researchandmarkets.com/research/dwwwgz/global_bipolar.

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For EST Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Related Topics: Mental Disorders Drugs

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For EST Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Related Topics: Mental Disorders Drugs